The Shortcomings Today: Navigating with a Blurry Map

Pharma insights teams are stuck in a painful trade-off: they can be fast, or they can be right—but rarely both. Syndicated reports offer solid benchmarks, but by the time they land, the market has already moved. Social listening only captures the loudest, least representative voices. Internal judgment is quick but impossible to defend. Meanwhile, traditional research still crawls at a snail’s pace while competitors sprint. The result? Leaders are forced to steer brands with a patchwork of biased, outdated, or incomplete data.